{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:44:58Z","timestamp":1788993898328,"version":"build-2803163510"},"reference-count":27,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Therapeutic plasma exchange (TPE) using exclusively albumin replacement fluid depletes coagulation factors, particularly fibrinogen, and concerns about performing multiple consecutive daily procedures due to iatrogenic bleeding exist. Fibrinogen testing to guide bleeding risk stratification is vague. We characterize our experience of changing our standard clinical practice by performing up to five consecutive daily TPE using exclusively albumin replacement fluid in conjunction with halting empiric coagulation testing (including fibrinogen testing) and fibrinogen supplementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this 5\u2010year prospectively monitored experience, patients received 3\u20135 consecutive daily TPE using exclusively albumin replacement fluid. Patients with active bleeding, personal or family bleeding history, therapeutic anticoagulant or antiplatelet drugs, thrombocytopenia, or major interventional procedure within 24\u2009h of TPE did not receive this updated treatment plan. Coagulation testing (including fibrinogen testing) was not ordered prior to any TPE. Events of interest were bleeding within 72\u2009h after any TPE procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 228 unique patients had a total of 264 treatment series with a total of 1351 TPE performed. Sixty\u2010eight patients had 84 series, 101 patients had 116 series, and 59 patients had 64 series with 3, 4, and 5 consecutive daily TPE, respectively. Fourteen early and minor bleeds, predominantly central venous catheter\u2010associated, occurred within 24\u2009h after TPE and were mild (bleeding rate 1.4% per consecutive daily TPE and 6.1% per patient).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings indicate that patients with low bleeding risk receiving up to five consecutive daily TPE using exclusively albumin replacement fluid without empiric coagulation testing (including fibrinogen testing) or fibrinogen supplementation experience only rare and mild bleeds.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.70159","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:30:46Z","timestamp":1774326646000},"page":"903-909","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiple consecutive daily therapeutic plasma exchange using exclusively albumin replacement fluid in low bleeding risk patients is associated with only rare and mild bleeds"],"prefix":"10.1111","volume":"66","author":[{"given":"Jay S.","family":"Raval","sequence":"first","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center  Albuquerque New Mexico USA"},{"name":"Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine University of Vermont  Burlington Vermont USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2779-1286","authenticated-orcid":false,"given":"Joseph R.","family":"Griggs","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center  Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres E.","family":"Mindiola Romero","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center  Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Reyes","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center  Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center  Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Ornelas","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center  Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizabeth","family":"Marinaro","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center  Albuquerque New Mexico USA"},{"name":"Vitalant  Scottsdale Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian A.","family":"Rollins\u2010Raval","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center  Albuquerque New Mexico USA"},{"name":"Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine University of Vermont  Burlington Vermont USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22043"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21973"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000367682"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21666"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.18320"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06968.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19360"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-016-0688-9"},{"key":"e_1_2_8_10_1","unstructured":"National Cancer Institute U.S. Department of Health and Human Services.Common Terminology Criteria for Adverse Events (CTCAE) v5.0. [cited 2020 Jan 3]. Available from:https:\/\/dctd.cancer.gov\/research\/ctep\u2010trials\/for\u2010sites\/adverse\u2010events\/ctcae\u2010v6.pdf"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03147.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214322"},{"key":"e_1_2_8_13_1","unstructured":"Medical Advisory Team New Mexico Department of Health.Supplement of the New Mexico crisis standards of care plan. Available from:https:\/\/cv.nmhealth.org\/wp-content\/uploads\/2020\/05\/NM-CSC-Plan-V.5.1.20.pdf"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15514"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15857"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00665.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02435.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31823a088c"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13249"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17865"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.01.003"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2023.103831"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.70079"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-024-05487-6"},{"issue":"1","key":"e_1_2_8_25_1","article-title":"Contribution of coagulopathy on the risk of bleeding after central venous catheter placement in critically ill thrombocytopenic patients","volume":"4","author":"Baarle FLF","year":"2022","journal-title":"Crit Care Explor"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqx056"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-020-00989-1"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb01172.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70159","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70159","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:27:20Z","timestamp":1778902040000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/trf.70159"],"URL":"https:\/\/doi.org\/10.1111\/trf.70159","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"2025-12-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}